Breakthrough Study Reveals Hypnosis as Drug-Free Solution for Chronic Pain Management

In a breakthrough that could reshape the landscape of chronic pain management, a team of researchers at the University of Washington has uncovered a drug-free therapy that silences the neural pathways responsible for pain signals and perception. Exclusive insights from the study reveal that hypnosis—far removed from the stereotypical image of a swinging pocket watch—offers a viable alternative to opioids, NSAIDs, and other medications that carry significant risks. The findings, published in the journal *Neurology*, have ignited hope among millions of Americans grappling with chronic back pain, a condition that affects 60 million people nationwide.

The stakes are high. Each year, 18,000 spinal cord injuries occur in the U.S., and 300,000 Americans live with the aftermath. Meanwhile, 31 million individuals suffer from low back pain at any given time, with 39 percent of adults reporting back pain within the past three months. Standard treatments like NSAIDs and acetaminophen can cause stomach bleeding, kidney damage, or liver injury, while opioids pose life-threatening risks of addiction and overdose. Now, a clinical hypnosis program has emerged as a safer, more sustainable solution.

Researchers recruited 127 adults with moderate-to-severe chronic back pain for a six-week trial. Half received hypnotic cognitive therapy (HYP-CT), while the other half continued their usual care, which often included opioids, anti-seizure drugs, or antidepressants. The HYP-CT group underwent six one-hour sessions conducted over the phone or via Zoom—eliminating the need for travel. The approach fused cognitive therapy with hypnosis, guiding participants into a relaxed state where they became receptive to suggestions that reshaped their thoughts about pain.

Dr. Charles Bombardier, the study's first author and a UW Medicine psychologist, emphasized the therapy's unique power: "Hypnosis helps patients be more open to ideas about changing their thinking and internalizing those ideas, so they become automatic." By week six, the HYP-CT group saw their average pain scores drop from 5.9 to 4.7—a 1.2-point reduction. By week 12, the score fell further to 4.5. Crucially, the effect did not fade. "The effect had actually increased at 12 weeks—six weeks after treatment had stopped," Bombardier noted.

The study's methodology was meticulous. To avoid relying on memory, researchers called participants four times over a week to collect pain ratings on a scale of 0 to 10. The results were striking: the HYP-CT group experienced a 1.5-point drop in pain intensity by week 12, while the usual care group showed minimal improvement. Dr. M Elena Mendoza, coauthor and research associate professor, explained that the therapy focused on reinforcing "reassuring thoughts" that alleviate pain and enhance coping. "We identified both helpful and unhelpful thoughts but focused on the ones that help," she said.

Participants were also given recordings of their sessions and instructed to practice self-hypnosis daily. The accessibility of the program—delivered remotely and without medication—has sparked interest among clinicians and patients alike. For many, the therapy offers a lifeline amid the growing opioid crisis and the limitations of current pain management strategies.

As the study continues to unfold, its implications are profound. Hypnosis, once dismissed as quackery, is now proving to be a legitimate, science-backed intervention. For the millions living with chronic back pain, the promise of a drug-free, sustainable solution is nothing short of revolutionary.

Another six weeks later, the HYP-CT group's pain dropped a further 0.2 points, bringing their total reduction from baseline to 1.47 points. This marked a stark contrast to the usual care group, whose pain only decreased by 0.65 points over the same 12-week period. Researchers noted this gap as clinically meaningful, suggesting that hypnosis therapy could offer a more effective alternative for managing chronic pain. The results were especially striking for patients experiencing pure neuropathic pain—a burning, shock-like sensation often linked to spinal cord injuries. In this subgroup, the hypnosis group saw a nearly 1.8-point greater reduction in pain compared to usual care. However, for those with mixed pain types, the effect was far less pronounced and not statistically significant.

The implications of these findings are profound, particularly given the scale of chronic pain in the U.S. In 2023, 24 percent of adults reported experiencing chronic pain, with 8.5 percent describing it as high-impact. These rates were higher among women (25.4 percent and 9.6 percent) than men (23.2 percent and 7.3 percent). Researchers speculated that HYP-CT might be uniquely suited for central neuropathic pain, a condition that has long resisted conventional treatments. Dr. Mendoza emphasized the significance of the results: "Pain affects nearly every aspect of patients' lives, so it was encouraging to see such progress after just six sessions over six weeks."

The science behind this therapy lies in how the brain processes pain signals. When the spinal cord is injured, physical damage sends a signal to the brain, but the pain itself is a product of the brain's interpretation. This raw data—without inherent meaning—can be labeled as harmless, itchy, or agonizing, depending on neural activity. In chronic pain, especially after spinal cord injuries, the brain may become hyperactive, misinterpreting weak or scrambled signals as intense suffering. Hypnotic cognitive therapy works by retraining these neural pathways, teaching the brain to reinterpret pain signals and reduce their perceived intensity. This psychological intervention can alleviate physical pain even when the original injury remains unchanged.

Each year, nearly 18,000 Americans sustain spinal cord injuries, with an estimated 300,000 living with one today. These numbers add to the 60 million Americans who cope with chronic pain, a population that stands to benefit significantly from non-pharmacological treatments. The study's findings extended beyond pain relief. Depression scores in the hypnosis group dropped by about 2.2 points on average, while usual care patients saw minimal improvement. Sleep disturbances also improved, and by week 12, pain interference—how much pain disrupted daily life—had decreased more in the therapy group.

Patient satisfaction was overwhelmingly positive. At 12 weeks, 90 percent of those who received hypnosis therapy reported being satisfied or very satisfied with the treatment. About one-third said their pain had improved "much," and nearly half noted a meaningful decrease in pain levels. Adverse effects were rare, mild, and temporary, with some participants reporting dizziness, warmth, or brief heightened awareness of pain during relaxation sessions.

The study's authors concluded that six sessions of hypnosis therapy, delivered entirely via phone or video, could produce durable, clinically meaningful benefits for patients with hard-to-treat pain. Dr. Mark P. Jensen, senior author and professor of rehabilitation medicine, highlighted the broader implications: "This treatment not only works but has positive side effects like improved sleep and a greater sense of self-control. Based on the evidence, including its safety profile, this should be the first treatment offered to people with chronic pain.